English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/168492
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients

AuthorsSánchez-Muñoz, Laura; Morgado, J. M.; Álvarez-Twose, Iván; Matito, Almudena; García-Montero, Andrés ; Teodosio, Cristina; Jara-Acevedo, Maria; Mayado, Andrea; Mollejo, Manuela; Caldas, Carolina; Gonzalez-de-Olano, David; Escribano, Luis; Orfao, Alberto
KeywordsKIT mutation
Systemic mastocytosis
Reference centre
Rare disease
Flow cytometry
Issue Date2016
PublisherJohn Wiley & Sons
CitationBritish Journal of Haematology 172(1): 56-63 (2016)
AbstractThe diagnosis of 'rare diseases', such as mastocytosis, remains a challenge. Despite this, the precise benefits of referral of mastocytosis patients to highly specialized reference centres are poorly defined and whether patients should be managed at non-specialized versus reference centres remains a matter of debate. To evaluate the quality and efficiency of diagnostic procedures performed at the reference centres for mastocytosis in Spain (REMA) versus other non-reference centres, we retrospectively analysed a series of 122 patients, for the overall degree of agreement obtained for the World Health Organization (WHO) diagnostic and classification criteria betwen the referring and REMA centres. Our results showed that not all WHO diagnostic criteria were frequently investigated at the referring centres. Among the five WHO diagnostic criteria, the highest degree of agreement was obtained for serum tryptase levels [median 90% (95% confidence interval 84-96%)]; in turn, the overall agreement was significantly lower for the major histopathological criterion [80% (72-89%)], and the other three minor criteria: cytomorphology [68% (56-80%)] immunophenotyping of BM mast cells [75% (62-87%)] and detection of the KIT mutation [34% (8-60%)]. Referral of patients with diagnostic suspicion of mastocytosis to a multidisciplinary reference centre improves diagnostic efficiency and quality.
URIhttp://hdl.handle.net/10261/168492
Identifiersdoi: 10.1111/bjh.13789
e-issn: 1365-2141
issn: 0007-1048
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.